An upregulated expression of miR-20a promoted cellular drug resistance in CRC cell lines by targeting the Bcl-2 family member BCL2 Interacting Protein 2 (BNIP2), which is involved in the mitochondrial-mediated apoptosis pathway [208]. Here, BNIP2 is linked to colorectal carcinoma.